Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer

It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma
Read the full story on The Hindu Opens thehindu.com in a new tab
This is a short summary of a story published by The Hindu, shown with a link to the original. The full story, photo and reporting belong to The Hindu.










